FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on Todos Medical to Host Key Opinion Leader Webinar Entitled Tollovir : a Potential Treatment for Covid-19
Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, together with its 3CL biology joint venture partner NLC Pharma, Ltd., announced today that it will host a Key Opinion Leader (KOL) webinar entitled Tollovir : a Potential Treatment for Covid-19 on December 22, 2021 at 12:00pm ET.
This webinar will feature presentations from KOLs Yossef Av-Gay, Ph.D., from the University of British Columbia, and David Greenberg, MD, Faculty Member of Health Sciences of the Ben-Gurion University of the Negev.
• Dr. Av-Gay will discuss the mechanics of SARS-CoV-2 viral replication, 3CL protease biology and the relevant benefits of targeting 3CL protease with respect to viral replication, NEMO cleavage inhibition and its role potentially downregulating innate immune response to infection.
• Dr. Greenberg will present a review of SARS-CoV-2 virus biology and what the relevant therapeutic targets are for antiviral intervention, which interventions are being evaluated, and what occurs in the state of hyper-inflammation and cytokine storm that occurs.
For more information, please visit: Todos Medical Ltd.
About Buzz on the Street: One of FinancialBuzz.com’s latest corporate and financial news shows, covering the latest trending stock market news. Buzz on the Street looks to become a leader in corporate video news dissemination. Buzz on the Street is 100% original content, brought to you by Financial Buzz Media.
Sponsored Content Release. Click for Full Disclosure
The post “Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) to Host Key Opinion Leader Webinar on Covid first appeared on Financial Buzz .
For further details see:
“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) to Host Key Opinion Leader Webinar on Covid